(Q52042912)

20 April 2018

title

Independent prognostic significance of HER-2 oncoprotein expression in pN0 prostate cancer undergoing curative radiotherapy. (English)

1 reference

20 April 2018

adaptive radiation therapy

main subject

0 references

1

Alexander Fosså

1 reference

20 April 2018

4

Gustav Gaudernack

1 reference

20 April 2018

3

Sophie D Fosså

1 reference

20 April 2018

Wolfgang Lilleby

2

1 reference

20 April 2018

Goran Torlakovic

series ordinal

5

1 reference

20 April 2018

Aasmund Berner

series ordinal

6

1 reference

20 April 2018

language of work or name

English

0 references

publication date

1 May 2002

1 reference

20 April 2018

International Journal of Cancer

published in

1 reference

20 April 2018

volume

99

1 reference

20 April 2018

issue

1

1 reference

20 April 2018

page(s)

100-105

1 reference

20 April 2018

cites work

Cancer statistics, 1998.

1 reference

The role of active treatment in early prostate cancer

21 January 2018

1 reference

Role of HER2 gene overexpression in breast carcinoma

21 January 2018

1 reference

Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy

21 January 2018

1 reference

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

21 January 2018

1 reference

Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma

21 January 2018

1 reference

An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer . preliminary results and therapeutic implications.

21 January 2018

1 reference

Assessment of the need and appropriate method for testing for the human epidermal growth factor receptor-2 (HER2).

21 January 2018

1 reference

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase.

21 January 2018

1 reference

Transfected neu oncogene induces human prostate cancer metastasis

21 January 2018

1 reference

Overexpression of her-2/neu in human prostate cancer and benign hyperplasia

21 January 2018

1 reference

Overall survival after prostate-specific-antigen-detected recurrence following conformal radiation therapy

21 January 2018

1 reference

The c-erbB-2 protein in oncogenesis: molecular structure to molecular epidemiology

21 January 2018

1 reference

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

21 January 2018

1 reference

High-titer HER-2/neu protein-specific antibody can be detected in patients with early-stage breast cancer

21 January 2018

1 reference

The molecular and cellular biology of HER2/neu gene amplification/overexpression and the clinical development of herceptin (trastuzumab) therapy for breast cancer.

21 January 2018

1 reference

Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia

21 January 2018

1 reference

Prognostic factors for clinically localized prostate carcinoma: analysis of 938 patients irradiated in the prostate specific antigen era

21 January 2018

1 reference

Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology

21 January 2018

1 reference

HER2 in prostate cancer--a viable target or innocent bystander?

21 January 2018

1 reference

Cell proliferation rate by MIB-1 immunohistochemistry predicts postradiation recurrence in prostatic adenocarcinomas

21 January 2018

1 reference

Correlation of p34cdc2 cyclin-dependent kinase overexpression, CD44s downregulation, and HER-2/neu oncogene amplification with recurrence in prostatic adenocarcinomas

21 January 2018

1 reference

Fluorescence in situ hybridization study of HER-2/neu oncogene amplification in prostate cancer

21 January 2018

1 reference

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

21 January 2018

1 reference

Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer

21 January 2018

1 reference

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

21 January 2018

1 reference

Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10286

1 reference

20 April 2018

1 reference

20 April 2018